Critical illness polyneuropathy and myopathies;Critical illness-polyneuropathie und -myopathie

Intensivmedizin und Notfallmedizin

Volumn 40, Issue 3, 2003, Pages 203-211

  Hund, Ernst ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Muscle; Nerve; Neuromuscular complications; Sepsis

Indexed keywords

GLUCOCORTICOID; MUSCLE RELAXANT AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

CLINICAL FEATURE; CRITICAL ILLNESS; DISEASE ASSOCIATION; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; FLACCID PARALYSIS; HUMAN; HYPERGLYCEMIA; IMMUNE SYSTEM; INCIDENCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NEUROMUSCULAR DISEASE; NEUROTOXICITY; PATHOGENESIS; POLYNEUROPATHY; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0038627507     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00390-003-0370-7     Document Type: Review

References (99)

1. Alhan HC, Cakalagaoglu C, Hanci M, Toraman F, Idiz M, Kayacioglu I, Tarcan S (1996) Critical-illness polyneuropathy complicating cardiac operation. Ann Thorac Surg 61:1237-1239
2. Al-Lozi MT, Pestronk A, Yee WC, Flaris N, Cooper J (1994) Rapidly evolving myopathy with myosin-deficient muscle fibers. Ann Neurol 35: 273-279
3. Appadu BL, Greiff JMC, Thompson JP (1996) Postal survey on the longterm use of neuromuscular block in the intensive care. Intensive Care Med 22:862-866
4. Argov Z, Mastaglia FL (1979) Disorders of neuromuscular transmission caused by drugs. New Engl J Med 301:409-413
5. Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz NJ (1996) Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 22:849-855
6. Beutler B, Poltorak A (2001) Sepsis and evolution of the innate immune response. Crit Care Med 29:S2-6; discussion S6-7
7. Bleck TP (1996) The expanding spectrum of critical illness polyneuropathy (editorial). Crit Care Med 24: 1282-1283
8. Blobner M, Kochs E, Fink H, Mayer B, Veihelmann A, Brill T, Stadler J (1999) Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine. Anesthesiology 91: 999-1005
9. Bolton CF (1987) Electrophysiologic studies of critically ill patients. Muscle Nerve 10:129-135
10. Bolton CF (1996) Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 24:1408-1416
11. Bolton CF, Grand'Maison F, Parkes A, Shkrum M (1992) Needle electromyography of the diaphragm [see comments]. Muscle Nerve 15:678-681
12. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ (1986) Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 49:563-573
13. Bolton CF, Young GB (1997) Critical illness polyneuropathy due to parenteral nutrition [letter]. Intensive Care Med 23:924-925
14. Bolton CF, Young GB, Zochodne DW (1993) The neurological complications of sepsis. Ann Neurol 33:94-100
15. Brun-Buisson C (2000) The epidemiology of the systemic inflammatory response. Intensive Care Med 26(Suppl 1):S64-S74
16. Campellone JV, Lacomis D, Kramer DJ, Van Cott AC, Giuliani MJ (1998) Acute myopathy after liver transplantation. Neurology 50:46-53
17. Chad DA, Lacomis D (1994) Critically ill patients with newly acquired weakness: the clinicopathological spectrum. Ann Neurol 35:257-259
18. Cherington M (1998) Clinical spectrum of botulism. Muscle Nerve 21: 701-710
19. Coakley JH, Nagendran K, Ormerod IEC, Ferguson CN, Hinds CJ (1992) Prolonged neurogenic weakness in patients requiring mechanical ventilation for acute airflow limitation. Chest 101:1413-1416
20. Cooney RN, Kimball SR, Vary TC (1997) Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators. Shock 7:1-16
21. Coronel B, Mercatello A, Couturier J-C, Durand P-G, Holzapfell L, Blanc P-L, Robert D (1990) Polyneuropathy: potential cause of difficult weaning. Crit Care Med 18:486-489
22. Danon MJ, Carpenter S (1991) Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 14:1131-1139
23. de Letter MACJ, van Doorn PA, Savelkoul HFJ, Laman JD, Schmitz PIM, Op de Coul AAW, Visser LH et al (2000) Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokineexpression in the muscle tissue. J Neuroimmunol 106:206-213
24. de Letter M-ACJ, Schmitz PIM, Visser LH, Verheul FAM, Schellens RLLA, Op de Coul DAW, van der Meché FGA (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281-2286
25. de Sèze M, Petit H, Wiart L, Cardinaud JP, Gaujard E, Joseph PA, Mazaux JM et al (2000) Critical illness polyneuropathy. Eur Neurol 43:61-69
26. Deconinck N, Van Parijs V, BeckersBleukx G, Van den Bergh P (1998) Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromusc Dis 8: 186-192
27. Dimachkie MM, Austin SG, Slopis JM, Vriesendorp FJ (1995) Critical illness polyneuropathy in adolescence. J Child Neurol 10:409-411
28. Douglass JA, Tuxen DV, Horne M, Scheinkestel CD, Weinmann M, Czarny D, Bowes G (1992) Myopathy in severe asthma. Am Rev Respir Dis 146:517-519
29. DuBois DC, Almon RR (1981) A possible role for glucocorticoids in denervation atrophy. Muscle Nerve 4:370-373
30. Dunsire MF, Clarke SG, Stedmon JJ (2001) Undiagnosed myasthenia gravis unmasked by neuromuscular blockade. Br J Anaesth 86:727-730
31. Fuchs-Buder T (1998) Neuromuskuläres Monitoring. Eine Standortbestimmung. Anaesthesist 47:629-637
32. Geller TJ, Kaiboriboon K, Fenton GA, Hayat GR (2001) Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy? Neuromuscul Disord 11:579-582
33. Giostra E, Magistris MR, Pizzolato G, Cox J, Chevrolet JC (1994) Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Chest 106:210-220
34. Gooch JL, Suchyta MR, Balbierz JM, Petajan JH, Clemmer TP (1991) Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 19:1125-1131
35. Gorson KC, Ropper AH (1993) Acute respiratory failure neuropathy: a variant of critical illness polyneuropathy. Crit Care Med 21:267-271
36. Griffin D, Fairman N, Coursin D, Rawsthorne L, Grossman JE (1992) Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 102:510-514
37. Hansen-Flaschen J, Cowen J, Raps EC (1993) Neuromuscular blockade in the intensive care unit. More than we bargained for. Am Rev Respir Dis 147:234-236
38. Hanson P, Dive A, Brucher JM, Bisteau M, Dangoisse M, Deltombe T (1997) Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 20:1371-1380
39. Helliwell TR, Coakley JH, Wagenmakers AJM, Griffiths RD, Campbell IT, Green CJ (1991) Necrotizing myopathy in critically-ill patients. J Pathol 164:307-314
40. Hinder F, Ludemann P, Hinder S, Ringelstein EB, Van-Aken H (1997) Prolongierte Muskelschwache des Intensivpatienten unter besonderer Berücksichtigung der sog. Intensiv-Polyneuromyopathy. Anaesthesist 46: 211-219
41. Hinshaw LB (1996) Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 24:1072-1078
42. Hirano M, Ott BR, Raps EC, Minetti C, Lennihan L, Libbey NP, Bonilla E et al (1992) Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 42: 2082-2087
43. Hughes M, Grant IS, Biccard B, Nimmo G (1999) Suxamethonium and critical illness polyneuropathy. Anaesth Intensive Care 27:636-638
44. Hughes RAC, Bihari D (1993) Acute neuromuscular respiratory paralysis. J Neurol Neurosurg Psychiatry 56: 334-343
45. Hund E (1999) Myopathy in critically ill patients. Crit Care Med 27:2544-2547
46. Hund E, Abel R (2002) Spinaler Schock. Intensiv- und Notfallbehandlung 27:131-136
47. Hund E, Fogel W, Krieger D, DeGeorgia M, Hacke W (1996) Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 24:1328-1333
48. Hund E, Genzwürker H, Böhrer H, Jakob H, Thiele R, Hacke W (1997) Predominant involvement of motor fibres in patients with critical illness polyneuropathy. Br J Anaesthesia 78: 274-278
49. Hund E, Herkert M, Becker C-M, Hacke W (1996) A humoral neurotoxic factor in sera of patients with critical illness polyneuropathy (abstr) Ann Neurol 40:539
50. Hund E, Schuchardt V (1994) The porphyrias. In: Hacke W, Hanley DF, Einhäupl K, Bleck TP (Hrsg) Neurocritical Care. Springer, Berlin Heidelberg, pp 796-800
51. Lacomis D, Giuliani MJ, Van-Cott A, Kramer DJ (1996) Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 40:645-654
52. Lacomis D, Petrella JT, Giuliani MJ (1998) Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 21:610-617
53. Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, De Maria G et al (1996) Critical illness myopathy and neuropathy. Lancet 347:1579-1582
54. Latronico N, Rasulo FA, Recupero D, Beindorf A, Liberini P, Stefini R, Candiani A (1998) Acute quadriplegia with delayed onset and rapid recovery. Case report. J Neurosurg 88:769-772
55. Lee P, Tai DY (2001) Clinical features of patients with acute organophosphate poisoning requiring intensive care. Intensive Care Med 27:694-699
56. Leijten FSS, De Weerd AW, Poortvliet DCJ, De Ridder VA, Ulrich C, Harinck-De Weerd JE (1996) Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 22:856-861
57. Leijten FSS, De Werd AW, E H-DWK, De Ridder VA, Ulrich C (1997) Critical illness polyneuopathy due to parenteral nutrition [reply]. Intensive Care Med 23:925
58. Leijten FSS, Harinck-de Weerd JE, Poortvliet DCJ, de Weerd AW (1995) The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 274:1221-1225
59. Lewis KS, Rothenberg DM (1999) Neuromuscular blockade in the intensive care unit. Am J Health Syst Pharm 56:72-75
60. Maher J, Rutledge F, Remtulla H, Parkes A, Bernardi L, Bolton CF (1995) Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 21: 737-743
61. Marshall JC (2001) Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29:S99-106
62. Massa R, Carpenter S, Holland P, Karpati G (1992) Loss and renewal of thick myofilaments in glucocorticoidtreated rat soleus after denervation and reinnervation. Muscle Nerve 15: 1290-1298
63. Mertens HG (1961) Die disseminierte Neuropathie nach Koma. Nervenarzt 32:71-79
64. Mitch WE, Goldberg AL (1996) Mechanisms of muscle wasting. N Engl J Med 335:1897-1905
65. Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S (1997) Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23:1144-1149
66. Olsen CW (1956) Lesions of peripheral nerves developing during coma. JAMA 160:39-41
67. Op de Coul AAW, Verheul GAM, Leyten ACM, Schellens RLLA, Teepen JLJM (1991) Critical illness polyneuromyopathy after artificial respiration. Clin Neurol Neurosurg 93:27-33
68. Openshaw H (1997) Peripheral neuropathy after bone marrow transplantation. Biol Blood Marrow Transplant 3:202-209
69. Osler W (1892) The principles and practice of medicine. Appleton, New York, pp 114-118
70. Pamphlett R, Walsh J (1989) Infective endocarditis with inflammatory lesions in the peripheral nervous system. Acta Neuropathol 78:101-104
71. Ramsay DA, Zochodne DW, Robertson DM, Nag S, Ludwin SK (1993) A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 52:387-398
72. Rich MM, Pinter MJ, Kraner SD, Barchi RL (1998) Loss of electrical excitability in an animal model of acute quadriplegic myopathy [see comments]. Ann Neurol 43:171-179
73. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ (1996) Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 46:731-736
74. Ruff RL (1998) Why do ICU patients become paralyzed? [editorial; comment]. Ann Neurol 43:154-155
75. Schaper A, Ebbecke M, Rosenbusch J, Desel H (2002) Fischvergiftung. Dt Ärztebl 99:A1151-A1156
76. Schattschneider J, Wasner G, Baron R (2001) Zytostatikainduzierte Polyneuropathien. Aktuelle Neurologie 28:53-61
77. Schwarz J, Planck J, Briegel J, Straube A (1997) Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle Nerve 20: 696-701
78. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD (1992) Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 327:524-528
79. Sheth RD, Bolton CF (1995) Neuromuscular complications of sepsis in children. J Child Neurol 10:346-352
80. Showalter CJ, Engel AG (1997) Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 20:316-322
81. Sladen RN (1995) Neuromuscular blocking agents in the intensive care unit: a two-edged sword. Crit Care Med 23:423-428
82. Spitzer R, Giancarlo T, Maher L, Awerbuch G, Bowles A (1992) Neuromuscular causes of prolonged ventilator dependency. Muscle Nerve 15: 682-686
83. Subramony SH, Carpenter DE, Raju S, Pride M, Evans OB (1991) Myopathy and prolonged neuromuscular blockade after lung transplant [see comments]. Crit Care Med 19:1580-1582
84. Tabarki B, Coffinieres A, Van Den Bergh P, Huault G, Landrieu P, Sebire G (2002) Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects. Arch Dis Child 86:103-107
85. Tennilä A, Salmi T, Pettilä V, Roine RO, Varpula T, Takkunen O (2000) Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26:1360-1363
86. Tepper M, Rakic S, Haas JA, Woittiez AJ (2000) Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 56:211-214
87. Thiele RI, Jakob H, Hund E, Genzwürker H, Herold U, Schweiger P, Hagl S (1997) Critical illness polyneuropathy: a new iatrogenically induced syndrome after cardiac surgery? Eur J Cardiothorac Surg 12:826-835
88. Toyka KV, Müllges W (1994) Myasthenia gravis and Lambert-Eaton myasthenic syndrome. In: Hacke W, Hanley DF, Einhäupl K, Bleck TP (Hrsg) Neurocritical Care. Springer, Berlin Heidelberg, pp 807-815
89. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367
90. Waclawik AC, Sufit RL, Beinlich BR, Schutta HS (1992) Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium. Neuromusc Disord 2:19-26
91. Waldhausen E, Keser G (1991) Lähmungen durch Kohlenhydrate unter der Intensivtherapie. Anaesthesist 40:332-338
92. Wheeler AP, Bernard GR (1999) Treating patients with severe sepsis. N Engl J Med 340:207-214
93. Wijdicks EFM, Litchy WJ, Harrison BA, Gracey DR (1994) The clinical spectrum of critical illness polyneuropathy. Mayo Clin Proc 69:955-959
94. Windebank AJ (1999) Chemotherapeutic neuropathy. Curr Opin Neurol 12:565-571
95. Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young B, Sibbald WJ (1991) Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176-184
96. Zifko UA (2000) Long-term outcome of critical illness polyneuropathy. Muscle Nerve Suppl 9:S49-S52
97. Zifko UA, Zipko HT, Bolton CF (1998) Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 159:186-193
98. Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA (1987) Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 110:819-842
99. Zochodne DW, Ramsay DA, Shelly S, Moffatt S (1994) Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 17:285-292